Deacetylated PCBP1 licenses PARP1 activity for DNA damage repair
Molecular Cell · 2026-07 · 86 (14) · 2703-2721.e8
DOI: 10.1016/j.molcel.2026.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-07. Verfasst von Yuxin Shu und 16 weiteren Autor:innen. Beteiligte Einrichtung: International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineeri…. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, DNA Repair, Heterogeneous-Nuclear Ribonucleoproteins, DNA Damage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Anhui Provincial Department of Education, Science, Technology and Innovation Commission of Shenzhen Municipality, National Key Research and Development Program of China.
Abstract (Originalsprache)
Poly (ADP-ribose) polymerase 1 (PARP1) is a DNA damage sensor and one of the initiating enzymes essential for DNA repair. Understanding how to control PARP1 activity is critical for developing strategies to maintain genome stability. Here, we report that the RNA-binding protein poly(rC)-binding protein 1 (PCBP1) interacts with and inhibits PARP1 activity under physiological conditions, and that this inhibition is relieved in the early phase of the DNA damage response. Mechanistically, histone deacetylase SIRT7 mediates the deacetylation of PCBP1 at K314 and K351, disrupting its interaction with the DNA-binding domain of PARP1 and thereby permitting PARP1 activation. Modulating PCBP1 expression or acetylation through gene editing or antagonistic peptides affects the efficiency of DNA damage repair in both cell and murine models. Reduced PCBP1 levels are associated with poor survival in cancer patients following radiotherapy. This regulatory role for PCBP1 in PARP1 activity may form the basis of a therapeutic strategy that combines the inhibition of PCBP1 deacetylation with DNA-damaging agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen Univers…
- Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, China.
Förderung
- Anhui Provincial Department of Education
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Shu, Y., Zhang, J., Zhou, L., Feng, T., Chen, F., Tang, H., Li, M., Qian, J., Qin, M., Wang, Z., Lu, X., He, X., Di, L., Huang, J., Zhu, Q., Tian, Y., & Zhu, W. G. (2026). Deacetylated PCBP1 licenses PARP1 activity for DNA damage repair. Molecular Cell, 86(14), 2703-2721.e8. https://doi.org/10.1016/j.molcel.2026.05.008
Vancouver
Shu Y, Zhang J, Zhou L, Feng T, Chen F, Tang H, et al. Deacetylated PCBP1 licenses PARP1 activity for DNA damage repair. Molecular Cell. 2026;86(14):2703-2721.e8. doi:10.1016/j.molcel.2026.05.008
BibTeX
@article{Shu2026,
author = {Shu, Yuxin and Zhang, Jun and Zhou, Linmin and Feng, Tingting and Chen, Feng and Tang, Huangqi and Li, Mengyan and Qian, Jinqin and Qin, Mengzhu and Wang, Zixiang and Lu, Xiaopeng and He, Xingkai and Di, Longjiang and Huang, Jinbo and Zhu, Qian and Tian, Yuan and Zhu, Wei-Guo},
title = {Deacetylated PCBP1 licenses PARP1 activity for DNA damage repair},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {14},
pages = {2703--2721.e8},
doi = {10.1016/j.molcel.2026.05.008}
}
EUVIMED